Novarad

Executive Summary

Novarad is a US-based medical imaging software company founded in 1988, offering enterprise digital health solutions including PACS, RIS, and its proprietary VisAR augmented reality surgical navigation platform. The company serves hospitals, clinics, and imaging centers globally with cloud, on-premises, and hybrid deployment models. With a strong foothold in radiology IT and growing interest in AR-assisted surgery, Novarad is positioned to benefit from the increasing digitization of healthcare and demand for precision medicine. However, as a private company with limited public disclosures, its growth trajectory and competitive positioning remain opaque. The company's long operating history and niche AR technology provide a differentiated value proposition, but regulatory and commercial adoption risks persist.

Upcoming Catalysts (preview)

• Q3 2026Potential FDA 510(k) clearance for expanded VisAR surgical navigation indications70% success
• Q4 2026Announcement of a major hospital system contract for cloud PACS/RIS50% success